Recombinant Human UCK2 Protein，His

The UCK2 (uridine-cytidine kinase 2) protein has garnered significant attention in recent years due to its essential role in nucleoside metabolism and potential implications in cancer therapy. UCK2 is primarily involved in the phosphorylation of uridine and cytidine, converting them into their respective monophosphate forms, which are crucial for nucleotide synthesis and, consequently, RNA and DNA biosynthesis. Dysregulation of UCK2 activity has been implicated in various malignancies, making it a target of interest in cancer research. Studies have shown that elevated levels of UCK2 can promote tumor cell proliferation and survival, suggesting that inhibition of its activity may offer therapeutic benefits. Furthermore, UCK2 is considered a promising biomarker for certain types of cancers, which has spurred interest in the development of specific inhibitors. The ability to produce recombinant UCK2 proteins allows for in-depth structural and functional studies, enabling researchers to explore its enzymatic mechanisms and interactions with potential inhibitors. Overall, UCK2's critical involvement in nucleoside metabolism and its association with tumorigenesis underscore its relevance in biomedical research, paving the way for novel strategies in cancer treatment and diagnosis.